https://www.selleckchem.com/products/mk-0752.html
Background The United Network of Organ Sharing (UNOS) heart allocation policy designates patients on ECMO or with nondischargeable, surgically implanted, nonendovascular support devices (TCS-VAD) to higher listing statuses. Objectives This study aimed to explore whether temporary circulatory support-ventricular assist devices (TCS-VAD) have a survival advantage over extracorporeal membrane oxygenation (ECMO) as a bridge to transplant. Methods The UNOS database was used to conduct a retrospective analysis of adult heart transplants perfo
Aimer
Commentaire
Partagez
